Video Experimental Relacionado
Updated: Jun 27, 2026
14:32
Deacetylation Assays to Unravel the Interplay between Sirtuins (SIRT2) and Specific Protein-substrates
Published on: February 27, 2016
DBC1 es un regulador negativo de SIRT1
Ja-Eun Kim1, Junjie Chen, Zhenkun Lou
1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Nature
|February 1, 2008
Resumen
Deleted in Breast Cancer-1 (DBC1) inhibe directamente la actividad de SIRT1, una proteína relacionada con el envejecimiento y el cáncer. La reducción de DBC1 mejora la SIRT1
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Biología celular Biología celular.
- La bioquímica es la bioquímica.
Sus antecedentes:
- La proteína deacetilasa dependiente de NAD Sir2 (regulador de información silenciosa 2) es crucial para regular la vida útil de los organismos.
- SIRT1, el homólogo mamífero de la levadura Sir2, juega un papel en diversas funciones celulares y potencialmente en la tumorigénesis.
- Si bien las funciones celulares de SIRT1 están bien estudiadas, su regulación de la actividad sigue siendo menos comprendida.
Objetivo del estudio:
- Investigar los mecanismos reguladores de la actividad de SIRT1.
- Para identificar las proteínas que interactúan con y modulan la función de SIRT1.
- Explorar las implicaciones de la regulación de SIRT1 en el envejecimiento y el cáncer.
Principales métodos:
- Los ensayos de coinmunoprecipitación detectan la formación de complejos proteicos entre DBC1 y SIRT1.
- Ensayos in vitro e in vivo para medir la actividad de la desacetilasa SIRT1.
- Técnicas de silenciamiento de genes (por ejemplo, siRNA) para regular a la baja la expresión de DBC1.
- Análisis de la inducción de la apoptosis después del estrés genotóxico.
Principales resultados:
- Deleted in Breast Cancer-1 (DBC1) forma un complejo estable con SIRT1.1.
- DBC1 interactúa directamente con y inhibe la actividad de SIRT1 tanto in vitro como in vivo.
- La regulación a la baja de la expresión de DBC1 aumenta la inhibición mediada por SIRT1 de la apoptosis inducida por el estrés genotóxico.
Conclusiones:
- DBC1 actúa como un regulador negativo directo de la actividad de SIRT1.
- Estos hallazgos proporcionan nuevos conocimientos sobre la regulación de SIRT1.
- La interacción entre DBC1 y SIRT1 tiene implicaciones significativas para la comprensión de los mecanismos moleculares subyacentes al envejecimiento y el cáncer.
Videos de Conceptos Relacionados
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...